Skip to content
Home/Companies/Biotech/Maxion Therapeutics
MT

Maxion Therapeutics

Biotech·UK·Active·3yr hold

Maxion Therapeutics is a healthcare company, headquartered in United Kingdom.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Maxion Therapeutics?

Maxion Therapeutics is currently owned by LifeArc through LifeArc Ventures (1992 vintage), since 2023.

Hand-verified · updated 2026-04-21

LifeArc
Investor
LifeArc
LifeArc Ventures · 1992 · Life Sciences VC

Key facts

HQUnited Kingdom
SectorHealthcare

More from LifeArc Ventures

Other portfolio companies in the same fund.

Exciva
Active
BiotechGermany· 2026
GlycoEra
Active
BiotechSwitzerland· 2025
Hillstar Bio
Active
BiotechUnited States· 2025
Tribune Therapeutics
Active
BiotechSweden· 2025
Fluid Biomed
Active
MedTechCanada· 2024
Affect Therapeutics
Active
HealthTechUnited States· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings